Patent · US Active

HCV polymerase inhibitors

US9481703B2 · kind B2 · utility

39Cited by

3References

23Claims

0Family size

Assignee

MEDIVIR AB · SE

Inventors

Genadiy Kalayanov · Huddinge, SE
Staffan Torssell · Bromma, SE
Horst Wahling · Huddinge, SE

Key dates

Filing date	Feb 27, 2015
Grant date	Nov 1, 2016
Priority date	—
Expiry date	Feb 27, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H23/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides compounds of the formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.